4//SEC Filing
McLoughlin Margaret 4
Accession 0001415889-25-001164
CIK 0001662774other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 7:33 PM ET
Size
5.7 KB
Accession
0001415889-25-001164
Insider Transaction Report
Form 4
McLoughlin Margaret
Director
Transactions
- Award
Director Stock Option (right to buy)
2025-01-02+31,613→ 31,613 totalExercise: $1.88Exp: 2035-01-02→ Common Stock (31,613 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal quarterly installments over a one year-period. The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2025 provided for under the Issuer's Outside Director Compensation Policy.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001770823
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 7:33 PM ET
- Size
- 5.7 KB